The ACTG is a global clinical trials network that conducts research to improve the management of HIV and its comorbidities; develop a cure for HIV; and innovate treatments for tuberculosis, hepatitis B, and emerging infectious diseases.
Our Impact and Reach
Since our founding in 1987, ACTG investigators and sites across four continents have served as major resources for HIV and other infectious disease research, treatment, care, and education in their communities.
47k+
participants
76
sites
15
countries
3k+
trials
Voices for the Community
Sign up to receive the latest updates from the ACTG
